Single-center Trial for the Validation of High-resolution Transrectal Ultrasound (Exact Imaging Scanner ExactVu) for the Detection of Prostate Cancer

UnknownOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

September 5, 2019

Primary Completion Date

April 30, 2021

Study Completion Date

December 31, 2021

Conditions
Prostate Cancer
Interventions
DEVICE

HR-TRUS

Medical procedures to be performed in the study consist of subject preparation and prostate imaging. The HR-TRUS exam will be done with a transrectal probe either the day before surgery, or in the OR right before surgery. The exam will be done in the same manner as during a regular transrectal ultrasound exam and no invasive procedures will be associated.

Trial Locations (1)

13009

RECRUITING

Institut Paoli Calmettes, Marseille

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Exact Imaging

INDUSTRY

lead

Institut Paoli-Calmettes

OTHER

NCT03679819 - Single-center Trial for the Validation of High-resolution Transrectal Ultrasound (Exact Imaging Scanner ExactVu) for the Detection of Prostate Cancer | Biotech Hunter | Biotech Hunter